A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
Status:
Recruiting
Trial end date:
2023-04-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of nipocalimab versus
placebo in participants with moderate to severe active rheumatoid arthritis (RA).